Shin Jieun, Maekawa Tomoki, Abe Toshiharu, Hajishengallis Evlambia, Hosur Kavita, Pyaram Kalyani, Mitroulis Ioannis, Chavakis Triantafyllos, Hajishengallis George
Department of Microbiology, Penn Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Department of Preventive and Restorative Sciences, Division of Pediatric Dentistry, Penn Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Sci Transl Med. 2015 Sep 30;7(307):307ra155. doi: 10.1126/scitranslmed.aac5380.
DEL-1 (developmental endothelial locus-1) is an endothelial cell-secreted protein that regulates LFA-1 (lymphocyte function-associated antigen-1) integrin-dependent leukocyte recruitment and inflammation in various tissues. We identified a novel regulatory mechanism of DEL-1 in osteoclast biology. Specifically, we showed that DEL-1 is expressed by human and mouse osteoclasts and regulates their differentiation and resorptive function. Mechanistically, DEL-1 inhibited the expression of NFATc1, a master regulator of osteoclastogenesis, in a Mac-1 integrin-dependent manner. In vivo mechanistic analysis has dissociated the anti-inflammatory from the anti-bone-resorptive action of DEL-1 and identified structural components thereof mediating these distinct functions. Locally administered human DEL-1 blocked inflammatory periodontal bone loss in nonhuman primates-a relevant model of human periodontitis. The ability of DEL-1 to regulate both upstream (inflammatory cell recruitment) and downstream (osteoclastogenesis) events that lead to inflammatory bone loss paves the way to a new class of endogenous therapeutics for treating periodontitis and perhaps other inflammatory disorders.
DEL-1(发育性内皮位点-1)是一种内皮细胞分泌的蛋白质,可调节LFA-1(淋巴细胞功能相关抗原-1)整合素依赖性白细胞在各种组织中的募集和炎症反应。我们在破骨细胞生物学中发现了DEL-1的一种新的调节机制。具体而言,我们发现人类和小鼠破骨细胞均表达DEL-1,并调节其分化和吸收功能。从机制上来说,DEL-1以Mac-1整合素依赖性方式抑制破骨细胞生成的主要调节因子NFATc1的表达。体内机制分析已将DEL-1的抗炎作用与抗骨吸收作用区分开来,并确定了介导这些不同功能的结构成分。局部施用人类DEL-1可阻止非人类灵长类动物的炎症性牙周骨丧失,这是人类牙周炎的相关模型。DEL-1调节导致炎症性骨丧失的上游(炎症细胞募集)和下游(破骨细胞生成)事件的能力,为治疗牙周炎及其他炎症性疾病的新型内源性疗法铺平了道路。